Merck has entered a new collaboration with the International Diabetes Federation (IDF) to implement education and communications activities, in a bid to help address type 2 diabetes.
The IDF identifies diabetes as one of the largest global health emergencies of the 21st century and type 2 diabetes to be the most common form of the disease.
Merck Healthcare CEO and executive board member Dr Belén Garijo said: “Merck shares the IDF’s vision of promoting diabetes care and prevention worldwide, and we are committed to helping improve the lives of people living with or at risk of Type 2 diabetes.
“The IDF’s prestigious platforms, such as the online School of Diabetes and World Diabetes Day, provide a valued way for our joint education and awareness initiatives to reach and empower people with the knowledge they need in the fight against diabetes.”
Currently available on the IDF’s School of Diabetes website, the first partnership activity between the two organisations is a Continuing Medical Education (CME)-accredited, IDF-certified healthcare professional (HCP) course that imparts knowledge on the prevention of type 2 diabetes.
The course has been developed with an educational grant from Merck and allows unlimited access for HCPs worldwide.
IDF president Dr Shaukat Sadikot said: “The world is facing a rising prevalence and incidence of type 2 diabetes, due to limited knowledge on prevention and insufficiently informed self-management.
“Healthcare professionals have an important role to play to tackle this issue. Our self-paced online short course aims to enhance their knowledge and provide evidence-based strategies for the prevention of type 2 diabetes.”